Silver–zirconia nanoparticles (Ag–ZrO 2 NPs) were synthesized via an in situ strategy at room temperature using NaBH 4 as a reducing agent. The surface modification of ZrO 2 nanoparticles with nano silver was confirmed through various characterization techniques including Fourier Transform Infrared Spectroscopy (FTIR), UV–vis Diffuse Reflectance Spectroscopy (UV–vis DRS), X-ray Diffraction (XRD), and Field Emission Scanning Electron Microscopy (FESEM). The obtained results demonstrated that Ag nanoparticles, with a crystallite size of approximately 12 nm, were uniformly distributed on the surface of ZrO 2 nanoparticles. The incorporation of Ag nanoparticles to the ZrO 2 nanoparticles led to increasing the light absorption ability and reducing the band gap of Ag–ZrO 2 nanoparticles, thereby enhancing their photocatalytic performance under infrared lamp exposure. When 1 g/L of Ag–ZrO 2 nanoparticles was employed to methylene blue (MB) solution, the degradation of MB reached 90 % after 5 h of exposure. Additionally, the Ag–ZrO 2 nanoparticles exhibited a high antibacterial activity against two bacterial strains, E. coli and S. aureus . These findings highlight the potential of Ag–ZrO 2 nanoparticles as effective materials for environmental pollution treatment through advanced oxidation processes.
No takes yet. Share an insight, caveat, or question.
Dao et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: